Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00137254 · ClinicalTrials.gov registry record · NA
Insulin on Post Burn Hypermetabolism
A NA study, sponsored by United States Army Institute of Surgical Research.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00137254: Completed NA study, sponsored by United States Army Institute of Surgical Research.
NCT00137254 is a NA study that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00137254, a NA study, has completed, sponsored by United States Army Institute of Surgical Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effects of insulin on helping burn patients recover faster from their burns.
Interventions
- DRUG Indocyanine Green
- DRUG Insulin
- DRUG Stable Isotopes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00137254 record still lists
NCT00137254 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Indocyanine Green is the first listed.
NCT00137254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00137254 about?
NCT00137254 is a clinical study titled "Insulin on Post Burn Hypermetabolism". The purpose of this study is to examine the effects of insulin on helping burn patients recover faster from their burns.
What is the current status of trial NCT00137254?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2005-12. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00137254?
The interventions under investigation include: Indocyanine Green (DRUG), Insulin (DRUG), Stable Isotopes (DRUG).
Who is sponsoring clinical trial NCT00137254?
This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00137254's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia